Attend one of the most popular events at The Cove in South San Francisco on Wednesday. See the latest life science products, technologies and services from over 40 leading industry suppliers, and network with professionals in our industry while enjoying food and refreshments, giveaways and raffle prizes. No cost to attend. REGISTER» Hosted by:
The Battle of the BioTech Bands is heading West! After an incredible run in Boston—including our milestone 10th anniversary this May and over $1.5 million raised since inception—we’re excited to grow even bigger. We’re expanding our reach with a brand-new West Coast battle. REGISTER» Hosted by:
In this presentation, the speakers will summarize the 2025 cohort of new drugs approved by the FDA. Statistics on the overall cohort will be discussed, followed by a short summary of key features of approved drugs. The speakers will also highlight case studies with interesting discovery and development stories. REGISTER» Hosted by:
Developing biopharmaceutical formulations that offer maximum patient convenience without sacrificing safety and efficacy for entities such as mAbs, antibody drug conjugates, and Fc-conjugates among others is increasingly complex.. Many drugs now require doses for subcutaneous delivery beyond what can be achieved with a 1 mL injection of an aqueous formulation. A significant hurdle in meeting..
As drug discovery evolves, screening efficiency is critical to R&D success. Traditional methods often fall short when addressing complex targets and high-throughput demands. Functional cell lines offer a scalable solution with standardized design, precise engineering, and consistent performance—enabling faster and more accurate drug screening. In this webinar, we’ll explore how cell-based platforms are transforming early-stage..
Come hear pitches from leading Japan-focused strategic investors and pharmaceutical companies including AN Ventures, Astellas, Chugai Pharmaceuticals, Daiichi Sankyo, Nippon Life, Ono Pharmaceuticals and Recor Medical. Our presenters will share their investment and partnering priorities with the audience, and tell you how to connect with them to discuss strategic partnering opportunities. This is an amazing..
Disease is driven by complex biological networks that remain only partially understood until experimentally resolved as a whole. Targets and compounds advance without clear biological understanding, leading to failure. AI and large-scale experimental data have scaled hypotheses and insights. The bottleneck now shifts to biological resolution. Static data, including omics, cannot capture cellular biology in..
Investigational new drug (IND) application is an important milestone that marks the entry of a molecule into clinical development. Knowing the objectives, expectations, and processes of assembling and filing an IND is the key to not only a successful filing but also a promising clinical development path forward. Often, there are cases where too many..
Science is evolving—is the way we train the next generation of experts keeping pace? 🧬📖 Digital Science, Macmillan Learning, Springer Nature, and Scientific American are hosting a joint summit in San Francisco to tackle the evolution of the scientific workforce. This isn't just a conversation for educators; it’s a vital touchpoint for industry leaders and..